HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stanley S Stylli Selected Research

Stanley S Stylli Research Topics

Disease

19Neoplasms (Cancer)
10/2023 - 05/2005
18Glioblastoma (Glioblastoma Multiforme)
10/2023 - 01/2015
15Glioma (Gliomas)
01/2022 - 05/2005
5Brain Neoplasms (Brain Tumor)
10/2022 - 10/2018
2Gliosis
12/2023 - 08/2004
2Pathologic Processes
12/2019 - 04/2017
2Colorectal Neoplasms (Colorectal Cancer)
12/2018 - 05/2014
2Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
05/2018 - 04/2017
2Intracranial Vasospasm
05/2018 - 04/2017
2Seizures (Absence Seizure)
08/2015 - 01/2015
1Disease Progression
12/2023
1Neuroinflammatory Diseases
12/2023
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2023
1Multiple Sclerosis
12/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2023
1Astrocytoma (Pilocytic Astrocytoma)
06/2023
1Parkinson Disease (Parkinson's Disease)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019
1Philadelphia Chromosome
01/2019
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2019
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2019
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2019
1Leukemia
01/2019
1Neurologic Manifestations (Neurological Manifestations)
05/2018
1Hyponatremia
05/2018
1Carcinoma (Carcinomatosis)
05/2014

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
10/2022 - 11/2015
4Temozolomide (Temodar)FDA LinkGeneric
08/2023 - 01/2018
3Proteins (Proteins, Gene)FDA Link
12/2019 - 09/2014
3MicroRNAs (MicroRNA)IBA
01/2018 - 11/2015
2Glial Fibrillary Acidic ProteinIBA
12/2023 - 08/2004
2ponatinibIBA
01/2019 - 12/2018
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
12/2018 - 01/2014
2CytokinesIBA
10/2018 - 01/2014
2PPAR-gamma AgonistsIBA
08/2015 - 01/2015
2Glutamic Acid (Glutamate)FDA Link
08/2015 - 01/2015
2Peptide Hydrolases (Proteases)FDA Link
09/2014 - 08/2009
21-phenyl-3,3-dimethyltriazene (PDT)IBA
07/2006 - 05/2005
1Myelin-Oligodendrocyte GlycoproteinIBA
12/2023
1tonabersatIBA
12/2023
1InflammasomesIBA
12/2023
1CalciumIBA
12/2023
1Myelin Basic ProteinIBA
12/2023
1Connexin 43 (Connexin43)IBA
12/2023
1Coloring Agents (Dyes)IBA
06/2023
1Extracellular Matrix ProteinsIBA
06/2023
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1Interleukin-10 (Interleukin 10)IBA
11/2021
1CateninsIBA
01/2021
1Adenosine Triphosphatases (ATPase)IBA
01/2021
1Ion Channels (Ion Channel)IBA
10/2020
1Nucleic AcidsIBA
12/2019
1LipidsIBA
12/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1Phosphotransferases (Kinase)IBA
01/2019
1Dynamin IIIBA
01/2019
1Dynamins (Dynamin)IBA
01/2019
1dynole 34-2IBA
01/2019
1Tyrosine (L-Tyrosine)FDA Link
01/2019
1tyrosine receptor (receptor, tyrosine)IBA
01/2019
1GTP Phosphohydrolases (GTPases)IBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
10/2018
1InterleukinsIBA
10/2018
1Arginine Vasopressin (Argipressin)IBA
05/2018
1Vasopressins (Vasopressin)IBA
05/2018
1ImmunosorbentsIBA
05/2018
1SodiumIBA
05/2018
1EnzymesIBA
05/2018
1GelatinIBA
01/2018
1Proteasome Endopeptidase Complex (Proteasome)IBA
05/2016
1carfilzomibIBA
05/2016
1Gabexate (Foy)IBA
05/2016
1nafamostatIBA
05/2016
1Bortezomib (Velcade)FDA Link
05/2016
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2016
1Proteasome InhibitorsIBA
05/2016
1Cysteine (L-Cysteine)FDA Link
08/2015
1Pioglitazone (Actos)FDA Link
08/2015
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
08/2015
1Excitatory Amino Acid Transporter 2IBA
08/2015
1PPAR gammaIBA
08/2015
1LuciferasesIBA
05/2015
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2015
1Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2015
1src-Family KinasesIBA
09/2014
1Messenger RNA (mRNA)IBA
09/2014
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2014
1Protein Tyrosine PhosphatasesIBA
05/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
05/2014
1ErbB Receptors (EGF Receptor)IBA
05/2014
1Cetuximab (Erbitux)FDA Link
05/2014

Therapy/Procedure

21Therapeutics
10/2023 - 07/2006
3Photochemotherapy (Photodynamic Therapy)
08/2006 - 05/2005
2Radiotherapy
08/2023 - 11/2021
1Aftercare (After-Treatment)
10/2023
1Drug Therapy (Chemotherapy)
11/2021
1Immunotherapy
07/2021
1Adjuvant Chemoradiotherapy
10/2019
1Transplantation
01/2019